Norethistorone therapy for bleeding due to gastrointestinal telangiectases in Glanzmann's thrombasthenia

British Journal of Haematology

Volumn 100, Issue 3, 1998, Pages 594-596

  Leach, M ^a   Makris, M ^a   Hampton, K K ^a   Preston, F E ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Gastrointestinal telangiectases; Glanzmann's thrombasthenia; Norethisterone

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; ESTRADIOL VALERATE; ETHINYLESTRADIOL PLUS NORETHISTERONE; FIBRINOGEN RECEPTOR; IRON; NORETHISTERONE; TRANEXAMIC ACID; ALLOANTIBODY; PROGESTERONE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLANZMANN DISEASE; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TELANGIECTASIA; THROMBOCYTE TRANSFUSION; BLOOD TRANSFUSION; CHRONIC DISEASE; IMMUNOLOGY;

ADULT; BLOOD TRANSFUSION; CHRONIC DISEASE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; ISOANTIBODIES; NORETHINDRONE; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROGESTERONE CONGENERS; TELANGIECTASIS; THROMBASTHENIA;

EID: 0031594653     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00601.x     Document Type: Article

References (12)

1. Boley, S.J., Sammartano, R., Adams, A., DiBiase, A., Kleinhaus, S. & Sprayregen, S. (1977) On the nature and etiology of vascular ectasias of the colon: degenerative lesions of ageing. Gastroenterology, 72, 650-660.
2. Caen, J.P. (1989) Glanzmann's thrombasthenia. Baillieres Clinical Haematology, 2, 609-625.
3. Fressinaud, E. & Meyer, D. (1993) International survey of patients with von Willebrand disease and angiodysplasia. Thrombosis and Haemostasia, 70, 546.
4. George, J.N., Caen, J.P. & Nurden, A.T. (1990) Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood, 75, 1383-1395.
5. Inbal, A., Bank, I., Zivelin, A., Varon, D., Dardik, R., Shapiro, R., Rosenthal, E., Shenkman, B., Gitel, S. & Seligsohn, U. (1997) Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factor. British Journal of Haematology, 96, 179-182.
6. Lavabre, B.T., Navarro, M., Blanc, P., Larrey, D., Michel, H. & Rouanet, C. (1994) Von Willebrand's disease, digestive angiodysplasia, and estrogen-progesterone treatment. (Letter). American Journal of Hematology, 46, 254-255.
7. Moshkowitz, M., Arber, N., Amir, N. & Gilat, T. (1993) Success of estrogen-progesterone therapy in long-standing bleeding gastrointestinal angiodysplasia: report of a case. Diseases of the Colon and Rectum, 36, 194-196.
8. Okamura, T., Kanaji, T., Osaki, K., Kuroiwa, M., Yamashita, S. & Niho, Y. (1996) Gastrointestinal angiodysplasia in congenital platelet dysfunction. International Journal of Hematology, 65, 79-84.
9. Panes, J., Casadevall, M., Fernandez, M., Pique, J.M., Bosch, J., Casamitjana, R., Cirera, I., Bombi, J.A., Teres, J. & Rodes, J. (1994) Gastric microcirculatory changes of portal-hypertensive rats can be attenuated by long-term estrogen-progestagen treatment. Hepatology, 20, 1261-1270.
10. Van-Cutsem, E. (1995) Georges Brohee Prize. Oestrogen-progesterone, a new therapy of bleeding gastrointestinal vascular malformations. Acta Gastroenterologica Belgica, 56, 2-10.
11. Vase, P. (1981) Estrogen treatment of hereditary hemorrhagic telangiectasia: a double-blind controlled clinical trial. Acta Medica Scandinavica, 209, 393-396.
12. Warkentin, T.E., Moore, J.C. & Morgan, D.G. (1992) Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet, 340, 35-37.